[1]
“Pathological response rate in patients who achieve clinical response after neoadjuvant concurrent chemoradiotherapy in localized esophageal cancer”, J Fatima Jinnah Med Univ, vol. 14, no. 03, pp. 114–118, Dec. 2020, doi: 10.37018/qsqy1921.